Access cutting-edge diffuse large b-cell lymphoma treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.
Access diffuse large b-cell lymphoma specialists in New Orleans at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diffuse large b-cell lymphoma treatment provided free
This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refractory DLBCL.
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Check if you qualify for this diffuse large b-cell lymphoma clinical trial in New Orleans, LA
If you're searching for diffuse large b-cell lymphoma treatment options in New Orleans, LA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diffuse large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.